Senior Director of Assay Development, Fortis Life Sciences
BIOGRAPHY
DEC 07, 2023 10:00 AM PST
Multiplexed Lateral Flow Assay Development: Benefits, Risks, and Strategies for Success in Infectious Diseases and Oncology
Speaker
Event Date & Time
Date: December 7, 2023
Time: 10:00 AM (PST), 12:00 PM (CST), 1:00 PM (EST)
Abstract
Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, the use of multiplexing to meet market demands or resolve technical limitations has become more commonplace. However, multiplexing is not without its risks. Determining whether multiplexing is the correct path for your product and being able to predict potential pitfalls in development will both be essential to project success. In this webinar we will review the benefits and risks of multiplexing, discuss various development strategies, and examine common obstacles as they pertain to assays in the infectious diseases and oncology space.
Learning Objectives
- Gain an understanding of the benefits and risks associated with multiplexing.
- Learn about various development strategies for multiplex assays.
- Identify common obstacles that arise during the development of multiplex assays in the infectious diseases and oncology space.
- Review strategies for overcoming these obstacles and optimizing multiplex assay performance
Webinars will be available for unlimited on-demand viewing after live event.
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...